Prophylactic mastectomies and immediate breast reconstruction in patients at very high genetic risk: Our experience with 14 cases;Mastectomies prophylactiques et reconstruction immédiate chez les patientes à très haut risque génétique : notre expérience à propos de 14 cas

Annales de Chirurgie Plastique Esthetique

Volumn 53, Issue 4, 2008, Pages 325-333

  Missana, M C ^a   Chompret, A ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

BRCA; Immediate breast reconstruction; Nipple areolar complex preservation; Prophylactic mastectomy

Indexed keywords

EID: 47149106286     PISSN: 02941260     EISSN: 1768319X     Source Type: Journal    
DOI: 10.1016/j.anplas.2007.09.004     Document Type: Article

References (29)

1. Bowers D.G., and Radlauer C.B. Breast cancer after prophylactic subcutaneous mastectomies and reconstruction with silastic prosthesis. Plast Reconstr Surg 44 (1969) 541-544
2. Perrissi V.R. Subcutaneous mastectomy data: an interum report. Breast 5 (1979) 8-21
3. Eldar S., Meguid M.M., and Beatly J.D. Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg 148 (1984) 692-693
4. Goodnight J.E., Quagliana J.M., and Morton D.L. Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol 26 (1984) 198-201
5. Srivastava A., and Webster J.T. Isolated nipple recurrence seventeen years after subcutaneous mastectomy for breast cancer - a case report. Eur J Surg Oncol 13 (1987) 459-461
6. Salmon R.J., and Vilcoq J.R. Breast cancer after preventive subcutaneous mastectomy. Presse Med 24 (1995) 1167-1168
7. Rebbeck T.R., Friebel T., Lynch H.T., et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the prose Study Group. J Clin Oncol 22 (2004) 1055-1062
8. Hartmann L.C., Schaid D.J., Woods J.E., et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340 (1999) 77-84
9. Meijers-Heijboer H., van Geel B., van Putten W.L.J., et al. Breast cancer after bilateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345 (2001) 159-164
10. Meiser B., Butow P., Friedlander M., et al. Intention to undergo bilateral prophylactic mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol 18 (2000) 2250-2257
11. Hatcher M.B., Fallowfield L., and A'Hern R. The psychological impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semi-structured interviews. BMJ (2001) 322-376
12. Montgomery L.L., Tran K.N., Heelan M.C., et al. Issues of regrets in women with contralateral prophylactic mastectomies. Ann Surg Oncol 6 (1999) 546-552
13. Esplen M.J., Hunter J., Leszcz M., et al. A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer 101 (2004) 2327-2334
14. Metcalfe K.A., and Narod S.A. Breast cancer risk perception among women who have undergone bilateral prophylactic mastectomy. J Natl Cancer Inst 94 20 (2002) 1564-1569
15. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancer in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349 (1997) 1505-1510
16. Lakhani S.R., Van de Vijver M.J., Jacquemier J., et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor. Her2 and p 53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20 (2002) 2310-2318
17. Lynch B.J., Holden J.A., Buy S.S., et al. Pathobiologic characteristics of hereditary breast cancers. Hum Pathol 29 (1998) 1140-1144
18. Phillips K.A. Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. J Clin Oncol 18 21s (2000) 107s-112s
19. Robson M. Are BRCA1 and BRCA2 associated breast cancers different? Prognosis of BRCA1 associated breast cancer. J Clin Oncol 18 21S (2000) 113s-118s
20. Vaziri S.A.J., Krumroy L.M., Elson P., et al. Breast tumor immunophenotype of BRCA1 mutation carriers is influenced by age at diagnosis. Clin Cancer Res 7 (2001) 1937-1945
21. Eerola H., Vahteristo P., Sarantus L., et al. Survival of breast cancer patients in BRCA1, BRCA2 and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland. Int J Cancer 93 (2001) 368-372
22. Foulkes W.D., Chappuis P.O., Wong N., et al. Primary node-negative breast cancer in BRCA1 mutation carriers has a poor outcome. Ann Oncol 11 (2000) 307-313
23. Nicoletto M.O., Donach M., De Nicolo A., et al. BRCA1 and BRCA2 mutations as prognostic factors in clinical practice and genetic counseling. Cancer Treat Rev 27 (2001) 295-304
24. Stoppa-Lyonnet D., Ansquer Y., Dreyfus H., et al. Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol 18 (2000) 4053-4059
25. Haffty B.G., Harrold E., Khan A.J., et al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 359 (2002) 1471-1477
26. Turner B.C., Harrold E., Matloff E., et al. BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations. J Clin Oncol 17 (1999) 3017-3024
27. Frost M.H., Schaid D.J., Sellers T.A., et al. Long term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284 (2000) 319-324
28. Payne D.K., Biggs C., Tran K.N., et al. Women's regrets after bilateral prophylactic mastectomy. J Clin Oncol 7 (2000) 150-154
29. Spear S.L., Carter M.E., and Schwarz K. Prophylactic mastectomy: indications, options, and reconstructive alternatives. Plast Reconstr Surg 115 3 (2005) 891-909